Markets Not Available
7.5mg/5ml, 10mg/5ml, 30mg/5ml
Calcium Polystyrene Sulfonate
powder for oral susp
Registered (EU) Launched (UK)
UK, MT, CY, EL, IE
UK, FI, SE, NO, EL
NL, UK, IT, ES, DE, SE, NO, DK, EL
12.5mg/5ml, 50mg/5ml, 100mg/5ml
Registered (UK & EU)
UK, FR, EL
1 % w/v
- Yellow highlighted forms and strengths denote Added Value hybrid products (unique dosage forms and/or strengths).
- Products in red denote Controlled Substances (psychotropics and/or narcotics).
- Products marked with (*) are co-developed with HELM, who is liaised for licensing opportunities.
- All products developed, manufactured and supplied by Labomed (except solid/semi-solid/eyedrops forms where CMOs used for manufacturing).
- Labomed owns 16 Patent applications to EPO & PCT.